DAT-SPECT imaging
Dopamine-transporter imaging for diagnosis and progression tracking.
State of the art
No update yet for DAT-SPECT imaging. An update is a standalone state-of-the-art for the topic — what someone with Parkinson's needs to know about where this approach stands today.
-
Levodopa increases substantia nigra iron: implications for Parkinson's disease
The research adds to the rationale for using iron-sensitive MRI (quantitative susceptibility mapping) alongside functional imaging to monitor nigral integrity and the effects of treatment — a potential future clinical tool. -
Démence à corps de Lewy : voici pourquoi elle est confondue avec Parkinson et Alzheimer (et ce que ça change) - Cap Retraite
The article points to DaTSCAN (an imaging technique measuring dopamine-transporter function at synapses) as one of the tools neurologists use to distinguish LBD from Alzheimer's — relevant for Parkinson's patients whose diagnosis may need re-evaluation when prominent hallucinations or fluctuating cognition emerge.